Historically, there have been no accounts of an association between simple metopic ridging and the Chiari I malformation. We prospectively evaluated 50 children with simple metopic ridges and found that 30% of these patients had a Chiari I malformation. During the period in which this screening for simple metopic ridges was performed, only 9% of the total patient population (324) was diagnosed as having a Chiari I malformation. We hypothesize that small decreases in anterior fossa volume in children with a simple metopic ridge and no other clinical findings of trigonocephaly may increase their chance of having a Chiari I malformation that becomes symptomatic. In addition, simple metopic ridging should perhaps be added to the list of bony anomalies associated with the Chiari I malformation, such as atlantal assimilation and retroverted odontoid processes. Future studies aimed at calculating anterior fossa volumes in children with a Chiari I malformation and imaging all children with simple metopic ridges are now necessary to ascertain if there is an increased risk of these patients becoming symptomatic with a hindbrain hernia or having a hindbrain hernia, respectively.

1.
Cinalli G, Renier D, Sebag G, Sainte-Rose C, Arnaud E, Pierre-Kahn A: Chronic tonsillar herniation in Crouzon’s and Apert’s syndromes: The role of premature synostosis of the lambdoid suture. J Neurosurg 1995;83:575–582.
2.
Francis PM, Beals S, Rekate HL, Pittman HW, Manwaring K, Reiff J: Chronic tonsillar herniation and Crouzon’s syndrome. Pediatr Neurosurg 1992;18:202–206.
3.
Ito S, Matsui K, Ohsaki E, Goto A, Takagi K, Koresawa M, Ito S, Sekido K, Suzuki M, Torikai K, Aida N: A cloverleaf skull syndrome probably of Beare-Stevenson type associated with Chiari malformation. Brain Dev 1996;18:307–311.
4.
Saldino RM, Steinbach HL, Epstein CJ: Familial acrocephalosyndactyly (Pfeiffer syndrome). Am J Roentgenol Radium Ther Nucl Med 1972;116:609–622.
5.
Thompson DN, Harkness W, Jones BM, Hayward RD: Aetiology of herniation of the hindbrain in craniosynostosis. An investigation incorporating intracranial pressure monitoring and magnetic resonance imaging. Pediatr Neurosurg 1997;26:288–295.
6.
Venes JL: Arnold-Chiari malformation in an infant with Kleeblattschadel: An acquired malformation? Neurosurgery 1988;23:360–362.
7.
Sun PP, Persing JA: Craniosynostosis; in Albright AL, Pollack IF, Adelson PD (eds): Principles and Practice of Pediatric Neurosurgery. New York, Thieme, 1999, p 223.
8.
Oi S, Matsumoto S: Trigonocephaly (metopic synostosis). Childs Nerv Syst 1987;3:259–265.
9.
Genitori L, Cavalheiro S, Lena G, Dollo C, Choux M: Skull base in trigonocephaly. Pediatr Neurosurg 1991;17:175–181.
10.
Collmann H, Sörensen N, Krauss J: Consensus: Trigonocephaly. Childs Nerv Syst 1996;12:664–668.
11.
Dominguez R, Oh KS, Bender T, Girdany BR: Uncomplicated trigonocephaly – a radiographic affirmation of conservative therapy. Radiology 1981;140:681–688.
12.
Kolar JC, Salter EM: Preoperative anthropometric dysmorphology in metopic synosotosis. Am J Phys Anthropol 1997;109:341–351.
13.
Shuper A, Merlob P, Grunebaum M, Salomon H, Reisner MB: The incidence of isolated craniosynostosis in the newborn infant. Am J Dis Child 1985;139:85–86.
14.
Anderson FM, Gwinn JL, Todt JC: Trigonocephaly identity and surgical treatment. J Neurosurg 1962;19:723–730.
15.
Harwood-Nash DC, Fitz CR: Neuroradiology in Infants and Children. Saint Louis, Mosby, 1976, vol 1, p 737.
16.
Huang MHS, Mouradian WE, Cohen SR, Gruss JS: The differential diagnosis of abnormal head shapes: Separating craniosynostosis from positional deformities and normal variants. Cleft Palate Craniofac J 1998;35:204–211.
17.
Cohen MM Jr, MacLean RE: Craniosynostosis – Diagnosis, Evaluation, and Management, ed 2. New York, Oxford University Press, 2000, pp 115–118.
18.
Dhellemmes P, Pellerin P, Lejeune JP, Lepoutre F: Surgical treatment of trigonocephaly. Experience with 30 cases. Childs Nerv Syst 1986;2:228–232.
19.
Cohen MM Jr: Sutural biology and the correlates of craniosynostosis. Am J Med Genet 1993;47:581–616.
20.
Badie B, Mendoza D, Batzdorf U: Posterior fossa volume and response to suboccipital decompression in patients with Chiari I malformation. Neurosurgery 1995;37:214–218.
21.
Milhorat TH, Chou MW, Trinidad EM, Kula RW, Mandell M, Wolpert C, Speer MC: Chiari I malformation redefined: Clinical and radiographic findings for 364 symptomatic patients. Neurosurgery 1999;44:1007–1017.
22.
Piper JG, Menezes AH: Chiari malformation in the adult; in Menezes AH, Sonntag VK (eds): Principles of Spinal Surgery. New York, McGraw-Hill, 1996, pp 379–394.
23.
Stovner LJ, Bergan U, Nilsen G, Sjaastad O: Posterior cranial fossa dimensions in the Chiari I malformation: Relation to pathogenesis and clinical presentation. Neuroradiology 1993;35:113–118.
24.
Delashaw JB, Persing JA, Park TS, Jane JA: Surgical approaches for the correction of metopic synostosis. Neurosurgery 1986;19:228–234.
25.
Thompson DN, Malcolm GP, Jones BM, Harkness WJ, Hayward RD: Intracranial pressure in single-suture craniosynostosis. Pediatr Neurosurg 1995;22:235–240.
26.
Tubbs RS, Oakes WJ: Chiari malformations; in Winn R (ed): Youman’s Neurological Surgery, ed 5. Philadelphia, Saunders, in press.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.